MedPath

Primaquine Phosphate

PRIMAQUINE PHOSPHATE TABLETS, USP

Approved
Approval ID

1bfbf4ae-81b8-4160-a00d-6322aadd4b59

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 3, 2021

Manufacturers
FDA

Sanofi-Aventis U.S. LLC

DUNS: 824676584

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Primaquine Phosphate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0024-1596
Application NumberNDA008316
Product Classification
M
Marketing Category
C73594
G
Generic Name
Primaquine Phosphate
Product Specifications
Route of AdministrationORAL
Effective DateAugust 21, 2019
FDA Product Classification

INGREDIENTS (12)

PRIMAQUINE PHOSPHATEActive
Quantity: 15 mg in 1 1
Code: H0982HF78B
Classification: ACTIM
CARNAUBA WAXInactive
Code: R12CBM0EIZ
Classification: IACT
LACTOSE, UNSPECIFIED FORMInactive
Code: J2B2A4N98G
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
HYPROMELLOSE 2910 (15000 MPA.S)Inactive
Code: 288VBX44JC
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Primaquine Phosphate - FDA Drug Approval Details